ABSTRACT
Introduction
Hepatitis B and hepatitis C viruses are major health problems worldwide. It is estimated that about 350 million people are chronically infected with hepatitis B in the world. Also, around 160 million people have chronic hepatitis C worldwide. These infections can lead into cirrhosis, decompensated cirrhosis, hepatocellular carcinoma and death. Hemodialysis is the main renal replacement therapy in patients with end-stage kidney disease.
This treatment modality carries high risk of transmitting blood born infection such as hepatitis B virus, hepatitis C virus and human immunodeficiency virus to patients with chronic kidney disease.
(3)
Moreover, patients who undergo hemodialysis have lower immunity that makes them much more vulnerable to acquire such viruses and have lower response rate to hepatitis B vaccine.
(4)
In addition, hemodialysis patients are usually anemic, need blood transfusion and invasive procedures more than the general population which also put them at higher risk of being infected with these viruses. Therefore, patients undergoing hemodialysis are expected to have the highest rates of hepatitis B virus and hepatitis C virus infections and this is exactly what has been confirmed by the great majority of epidemiological studies which showed prevalence of hepatitis B and hepatitis C infections in hemodialysis units ranges from 1-20% and 1-55% respectively. The presence of hepatitis B virus and/or hepatitis C virus in patients with chronic kidney disease can also increase the morbidity and mortality in these patients. For example, the rate of rejection in kidney transplant and mortality are higher in patients with hepatitis C virus infection than patients without such infection.
(7) Also, the response rate to antiviral treatment is decreased and the side effects of antiviral drugs are higher in chronic kidney disease patients.
(8)
There are many risk factors which are associated with increased rates of blood born infections among hemodialysis patients. So, identifications of these risk factors and introduction of measures to address these factors have become a priority in hemodialysis units.
(9)
There are few studies on the prevalence of hepatitis B virus and hepatitis C virus infections in patients on hemodialysis as well as on variables associated with higher risks of these infections in Jordan. These studies have concluded that the prevalence of hepatitis C infection among hemodialysis patients were between 20-50%, and the prevalence of hepatitis B infection was 6%.
(15-20) However, the majority of these studies were single center and their sample size was small. Hence, the aim of this multicentre study is to find out the prevalence rate and different risk factors of these infections in Jordanian Royal Medical Services hospitals.
Methods
This is an observational cross sectional study which was performed in seven dialysis units at Royal Medical Services in Jordan as of May 2014. The records of patients on maintenance hemodialysis were reviewed by the investigators to determine the seropositivity and negativity of hepatitis B and hepatitis C, age, gender, duration of dialysis, duration of infection if applicable, past medical and surgical history, blood transfusion, family history of hepatitis in immediate family member and other relevant data.
In addition, all patients were interviewed and were asked specifically about various risk factors of acquiring hepatitis viruses such as dialysis outside their specified units, intravenous drug use, family history of hepatitis virus infection in immediate family member, dental procedures, immunization history and other pertinent information which was not clear on reviewing the records such as the duration of dialysis and duration of hepatitis infection. Also, data was collected regarding the serology and immunization status of dialysis staff and whether infection control measures were adopted in these units.
Dialysis units at Jordanian Royal Medical Services follow the standard infection control protocol which includes the use of disposable gloves, disposable kits, disposable needles, disposable dialyzers, single use vials and disinfection of surfaces. Disinfection of dialysis machines between hemodialysis sessions and at the end of day was done with the appropriate chemical solution in compliance with the manufacturers recommendations. Hepatitis B infected patients were dialyzed on dedicated machines, while there were no special machines designated for hepatitis C infected patients. All patients were given hepatitis B vaccine if they were not vaccinated previously.
Criteria:
Patients were considered infected with hepatitis B when they had positive hepatitis B surface antigen by 3rd generation ELISA test and were considered not infected when they had negative hepatitis B surface antigen in their serum.
Patients with positive hepatitis C virus antibody which was also determined by 3 rd generation ELISA test were regarded infected with hepatitis C virus, otherwise they were considered not infected if hepatitis C antibody was negative. When serological tests were positive they were confirmed by highly sensitive quantitative polymerase chain reaction in the main laboratory in concordance with our policy at Royal Medical Services.
Data which was collected was analyzed by simple statistics. The mean and the median were used to describe the central tendency of our data, while the range and standard deviation were used to describe the degree of dispersion of our data. Chi square was used to compare the differences between various categorical data frequencies and to calculate the probability value (P value). Student test (t. test) was used to compare the differences between continuous numerical data and to calculate the P-value to determine statistical significance. P value of less than or equal to 0.05 was considered significant in rejecting the null hypothesis and accepting the alternative hypothesis. The ethical committee of the Royal Medical Services has approved our study. Patients also consented to participate in this study. No specific medical or invasive intervention was used in this study.
Results
A total number of 712 patients were included in the study from 7 different centers in Royal Medical Services in Jordan. The mean age was 48, it ranged from 14 to 78 and the number of males was 401 (56%) while the females formed around 44% of the total sample. Most patients (70%) were between 21 and 60 years old (Table  I ). The average duration of dialysis was 58 months and it ranged from 1 month to 20 years. Ninety seven percent of patients received blood transfusion and hepatitis B vaccine. The prevalence of hepatitis B and hepatitis C were 7% and 16.5% respectively (Table II) (Table III) . Regarding patients with hepatitis C, age of the patient and the duration of dialysis were directly related with increasing risk of acquiring hepatitis C. The mean age for those with hepatitis C was 58 compared with 52 of those without hepatitis C infection and the mean duration of dialysis for hepatitis C infected patients was 68 months compared with only 58 months with no infection. Renal transplant, dialysis outside, family history of hepatitis C infection and past history of dental procedures were significantly associated with increased rates of hepatitis C infection with significant P-value. On the other hand, gender, history of blood transfusion and past surgical history were not statistically associated with increased risks of hepatitis C infection with Pvalue constantly above 0.05. Table (IV) gives more details on the potential risk factors which related to hepatitis C infection.
Discussion
This study revealed that the prevalence of hepatitis B infection in hemodialysis patients is 7% which is comparable to the prevalence of hepatitis B infection in general population in Jordan which ranges from 4% to 11%.
(10) This result could be due to hepatitis B vaccination and dialyzing hepatitis B infected patients on dedicated machines.
(11) Our results on the prevalence of hepatitis B infection among patients on hemodialysis are comparable to previous Jordanian studies and lower than some Arabian countries like Bahrain where the prevalence is around 11%. On the other hand the prevalence of hepatitis B in hemodialysis patients in western countries like UK and USA is below 1% which is much lower than our results and this
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is mostly due to lower prevalence of hepatitis B in their general population
The prevalence of hepatitis C was found to be 16.5% in our study which was much higher than its prevalence in general population (0.42-2%). (12, 22) This very high prevalence in comparison to the general population points to the importance of nosocomial transmission of hepatitis C among hemodialysis patients. The most important route is horizontal infection from patient to patient through the dialysis units staff themselves when there is a break in infection control procedures. Therefore, adherence to infection control measures is of paramount importance in controlling hepatitis C infection in dialysis facilities. Another controversial proposed route of hepatitis C is the dialysis machine itself where some studies proved its importance, while other studies negotiate against its role in hepatitis C transmission. Most international guidelines still do not recommend dialyzing hepatitis C infected patients on isolated machines. Prevalence of hepatitis C among hemodialysis patients in this study was lower than other Jordanian and Middle Eastern studies which ranged from 20%-50%. However it was much higher than western countries which was below 2%. In our study, vaccination against hepatitis B is one of the most protective factors in preventing hepatitis B transmission among hemodialysis patients with significant P-value of <0.001. In addition vaccination will prevent hepatitis B virus to dialysis staff. Hence, the current guidelines recommend hepatitis B vaccination for all patients who would receive maintenance hemodialysis and for all the staff of dialysis unit.
(1) However, family history and history of dialysis outside their specified unit were associated with increased risk of hepatitis B infection in dialysis patients. Most of the patients with hepatitis B have a family history of hepatitis and this reflects the mode of hepatitis B infection which is mostly perinatal or horizontal in a country with intermediate to high hepatitis B endemecity like Jordan. Age, gender, blood transfusion, duration of dialysis, renal transplant, exposure to a staff with hepatitis B, surgical and dental procedures were not associated with increased risk of hepatitis B infection in the current study.
Although many studies have related blood transfusion and duration of dialysis to higher rates of hepatitis B infection, our study has not found any association between these factors and hepatitis B infection and this could be due to universal vaccination of all patients and high risk groups, effective screening of blood in blood banks and strong adherence to infection control methods.
(11)
The situation was different in hepatitis C. The age and duration of dialysis were significantly related to higher rates of hepatitis C infection. This could be partially due to the dialysis itself and other procedures which are associated with dialysis such as blood transfusion, blood withdrawal for lab tests and the administration of parenteral medications in the dialysis setting. These factors combined with the lack of effective vaccine against hepatitis C contributes to increased rates of infection.
(13)
Kidney transplant was found also to be associated with hepatitis C infection and this could be attributed to the fact that most of those patients received their graft from Egyptian or Indian donors who have high prevalence of hepatitis C and many of these transplant procedures were done abroad and were also associated with dialysis outside and increased risk of acquiring hepatitis C infection.
(9) Family history of hepatitis C was found to be a risk factor of hepatitis C infection and this could due to the exposure to the same genetic and environmental risks.
Although blood transfusion was a risk factor of hepatitis C infection in some studies, the current study found no association and this could be the result of effective blood screening methods which was adopted since 1990s. Similarly, surgical procedures were not associated with increased risks of hepatitis C infection because of strict adherence to sterile technique, while dental procedures was found to be a risk factor of hepatitis C transmission.
(14)
This study has several limitations: it is a cross sectional study that was carried at one time point; there was no indication of the sequence of events so the cause effect relationship could not be ascertained and the number of patients was relatively small to generalize our results. Hence, more representative studies are needed to confirm our results.
Conclusion
The prevalence of hepatitis B in hemodialysis patient is almost similar to that of general population and vaccination against hepatitis B was strongly protective against infection. Hepatitis C prevalence is still high and more measures are needed to decrease its prevalence in this cohort of patients.
